Search Results 2101-2110 of 39177 for Two-phase

  1. Hear My Voice: A Chaplain-Led Spiritual Legacy Pilot Study For Patients With Advanced Diseases - Mayo Clinic

    ... two weeks after being interviewed and two weeks after receiving their ... Phase 2. Additional patients will include those with a diagnosis of end stage ...

  2. Amg 510 (Sotorasib) With Or Without Panitumumab In Advanced Solid Tumors: A Combomatch Treatment Trial - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  3. Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6) - Mayo Clinic

    In the later phase (phase ... There are also less common very early (phase 0) and later (phase 4) phases. ... 2-negative (HER2-negative) metastatic breast ...

  4. A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - Mayo Clinic

    The purpose of this study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult ...

  5. (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. Green Tea Extract Appears to Keep Cancer in Check in Majority of CLL Patients - Mayo Clinic News Network

    An extract of green tea appears to have clinical activity with low toxicity in chronic lymphocytic leukemia (CLL) patients who used it in a phase II clinical ...

  7. Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures - Mayo Clinic

    In the later phase (phase ... There are also less common very early (phase 0) and later (phase 4) phases. ... 2. Weight ≥ 40 kg 3. Scheduled complex cardiac ...

  8. HER2-positive breast cancer: What is it? - Mayo Clinic

    HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2). This protein ...

  9. An Adjuvant Study To Evaluate SMS001 (Paclitaxel) In Non-Small Cell Lung Cancer - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Zagociguat in Participants With Melas (Prizm) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...